Senolytic Cycling Schedules: Monthly, Quarterly, and Pulse Dosing

Expert Summary

No human trial has directly compared senolytic cycling frequencies. Based on senescent cell reaccumulation kinetics in animals (50% recovery within 4–8 weeks) and clinical trial designs, monthly cycling is preferred for individuals 55+ or with high inflammatory burden; quarterly is appropriate for prevention in those under 50.

Key Facts

Recommended Products

Frequently Asked Questions

What happens if I miss a cycle?

Senescent cells continue to accumulate during missed cycles, but the long-term impact of occasional missed cycles is modest. Resume on your regular schedule without doubling doses.

Should I take a break from senolytic cycling?

No evidence supports "senolytic holidays." Unlike some drugs that develop resistance, senescent cells remain sensitive to senolytic treatment regardless of prior cycling history.

Can I combine monthly fisetin with quarterly dasatinib?

Yes. This "layered" approach provides monthly natural senolytic maintenance plus quarterly pharmaceutical senolytic boost. The fisetin cycles and dasatinib cycles can overlap (fisetin on dasatinib days) or be alternated.

Scientific References